A detailed history of Cidel Asset Management Inc transactions in Novartis Ag stock. As of the latest transaction made, Cidel Asset Management Inc holds 2,009 shares of NVS stock, worth $209,498. This represents 0.02% of its overall portfolio holdings.

Number of Shares
2,009
Previous 14,503 86.15%
Holding current value
$209,498
Previous $1.54 Million 85.03%
% of portfolio
0.02%
Previous 0.02%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

SELL
$106.13 - $120.89 $1.33 Million - $1.51 Million
-12,494 Reduced 86.15%
2,009 $231,000
Q2 2024

Jul 19, 2024

BUY
$92.57 - $107.37 $1.34 Million - $1.56 Million
14,503 New
14,503 $1.54 Million

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $224B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Cidel Asset Management Inc Portfolio

Follow Cidel Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cidel Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Cidel Asset Management Inc with notifications on news.